A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema.

BACKGROUND Lung-volume-reduction surgery has been proposed as a palliative treatment for severe emphysema. Effects on mortality, the magnitude and durability of benefits, and criteria for the selection of patients have not been established. METHODS A total of 1218 patients with severe emphysema underwent pulmonary rehabilitation and were randomly assigned to undergo lung-volume-reduction surgery or to receive continued medical treatment. RESULTS Overall mortality was 0.11 death per person-year in both treatment groups (risk ratio for death in the surgery group, 1.01; P=0.90). After 24 months, exercise capacity had improved by more than 10 W in 15 percent of the patients in the surgery group, as compared with 3 percent of patients in the medical-therapy group (P<0.001). With the exclusion of a subgroup of 140 patients at high risk for death from surgery according to an interim analysis, overall mortality in the surgery group was 0.09 death per person-year, as compared with 0.10 death per person-year in the medical-therapy group (risk ratio, 0.89; P=0.31); exercise capacity after 24 months had improved by more than 10 W in 16 percent of patients in the surgery group, as compared with 3 percent of patients in the medical-therapy group (P<0.001). Among patients with predominantly upper-lobe emphysema and low exercise capacity, mortality was lower in the surgery group than in the medical-therapy group (risk ratio for death, 0.47; P=0.005). Among patients with non-upper-lobe emphysema and high exercise capacity, mortality was higher in the surgery group than in the medical-therapy group (risk ratio, 2.06; P=0.02). CONCLUSIONS Overall, lung-volume-reduction surgery increases the chance of improved exercise capacity but does not confer a survival advantage over medical therapy. It does yield a survival advantage for patients with both predominantly upper-lobe emphysema and low base-line exercise capacity. Patients previously reported to be at high risk and those with non-upper-lobe emphysema and high base-line exercise capacity are poor candidates for lung-volume-reduction surgery, because of increased mortality and negligible functional gain.

[1]  J. Manson,et al.  Obesity in the United States: a fresh look at its high toll. , 2003, JAMA.

[2]  G. Criner,et al.  Prospective Randomized Trial Comparing Bilateral Lung Volume Reduction Surgery to Pulmonary Rehabilitation in Severe Chronic Obstructive Pulmonary Disease , 1999 .

[3]  J H Shih,et al.  Sample size calculation for complex clinical trials with survival endpoints. , 1995, Controlled clinical trials.

[4]  R. Rogers,et al.  Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. , 1996, The New England journal of medicine.

[5]  D A Redelmeier,et al.  Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. , 1997, American journal of respiratory and critical care medicine.

[6]  T. Mineo,et al.  Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomized study. Pulmonary Emphysema Research Group. , 2000, The Annals of thoracic surgery.

[7]  D. Amar,et al.  Antifibrinolytic Therapy and Perioperative Blood Loss in Cancer Patients Undergoing Major Orthopedic Surgery , 2003, Anesthesiology.

[8]  Steven Piantadosi,et al.  Patients at high risk of death after lung-volume-reduction surgery. , 2001, The New England journal of medicine.

[9]  E. Russi,et al.  Gain and subsequent loss of lung function after lung volume reduction surgery in cases of severe emphysema with different morphologic patterns. , 2002, The Journal of thoracic and cardiovascular surgery.

[10]  M. Becklake,et al.  Single breath carbon monoxide diffusing capacity. , 1988, The American review of respiratory disease.

[11]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[12]  R. Kaplan,et al.  Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. , 1984, Journal of chronic diseases.

[13]  M. Moy,et al.  Comparison of physiological and radiological screening for lung volume reduction surgery. , 2001, American journal of respiratory and critical care medicine.

[14]  P. Jones.  Interpreting thresholds for a clinically significant change in health status in asthma and COPD , 2002, European Respiratory Journal.

[15]  W. Klepetko,et al.  Is long-term functional outcome after lung volume reduction surgery predictable? , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[17]  F. Sciurba,et al.  Lung volume reduction surgery for emphysema. , 1996, Chest.

[18]  N. Zamel,et al.  Lung function 4 years after lung volume reduction surgery for emphysema. , 1999, Chest.

[19]  G. Patterson,et al.  Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. , 1996, The Journal of thoracic and cardiovascular surgery.

[20]  J. Curtis,et al.  Short-term and long-term outcomes after bilateral lung volume reduction surgery : prediction by quantitative CT. , 2001, Chest.

[21]  B. Steele,et al.  Timed walking tests of exercise capacity in chronic cardiopulmonary illness. , 1996, Journal of cardiopulmonary rehabilitation.

[22]  D. Hansell,et al.  Effect of lung-volume-reduction surgery in patients with severe emphysema. , 2000, The New England journal of medicine.

[23]  Sarah E. Duffy,et al.  Rationale and design of the National Emphysema Treatment Trial (NETT): A prospective randomized trial of lung volume reduction surgery. , 1999, The Journal of thoracic and cardiovascular surgery.

[24]  A. Agresti.  An introduction to categorical data analysis , 1997 .

[25]  R. Kaplan,et al.  Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego. , 1998, Chest.